摘要
背景:中枢神经系统(CNS)的痴呆症和所有相关的神经退行性疾病是引起国际科学界极大兴趣的一个当前问题。这是由于这些疾病患者数量的增加。这些病症是一个严重的问题,不仅关系到病人的生活质量,还有社会为治疗所做的巨大的经济努力。目前有一些策略可用来防止上述疾病的进展或缓解症状。如果我们考虑阿尔茨海默病(AD)的特定病理,这个考虑尤其如此。 方法:我们使用PubMed或Scopus等不同的数据库对同行评议的文章进行文献检索,并利用不同的关键词和不同的逻辑运算符。 结果:98篇论文被纳入评论。四篇论文概述了世界各地的痴呆症背景。其余的论文集中在治疗AD的天然和半合成化合物的新的可能性。 结论:本综述的目的是对新型和有希望的天然产物和半合成化合物进行综述,这些化合物可能是开发新型潜在药物的先导化合物的来源,可能是治疗这种药物的有效治疗策略病理。
关键词: 痴呆症,阿尔茨海默病,β淀粉样蛋白,CNS,天然产物,半合成化合物。
Current Medicinal Chemistry
Title:An Overview of New Possible Treatments of Alzheimer's Disease, Based on Natural Products and Semi-Synthetic Compounds
Volume: 24 Issue: 34
关键词: 痴呆症,阿尔茨海默病,β淀粉样蛋白,CNS,天然产物,半合成化合物。
摘要: Background: Dementias and all related neurodegenerative diseases of the Central Nervous System (CNS) are a current issue arousing a great deal of interest in the international scientific community. This is due to the increasing number of patients suffering from these diseases. These pathologies represent a serious problem, not only concerning the quality of life of the patient, but in addition, the enormous economic efforts that society has to do for their treatment. There are currently a few strategies that are available in order to prevent the progression or to mitigate symptoms of the aforementioned diseases. This consideration is particularly true if we consider the specific pathology of Alzheimer's Disease (AD).
Methods: We performed a literature search for peer-reviewed articles using different databases, such as PubMed or Scopus, and exploiting different keywords and different logical operators.
Results: Ninety-eight papers were included in the review. Four papers give an overview of the background of the dementias all over the world. The remaining papers are focused on new possibilities of treatment with natural and semi-synthetic compounds for AD.
Conclusion: The aim of this review is to give an overview of new and promising natural products and semi-synthetic compounds which could represent a source of “lead compounds” for the development of new potential drugs that could be a valid therapeutic strategy for the treatment of this pathology
Export Options
About this article
Cite this article as:
An Overview of New Possible Treatments of Alzheimer's Disease, Based on Natural Products and Semi-Synthetic Compounds, Current Medicinal Chemistry 2017; 24 (34) . https://dx.doi.org/10.2174/0929867324666170712161829
DOI https://dx.doi.org/10.2174/0929867324666170712161829 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Membrane Interactions of Oligomeric Alpha-Synuclein: Potential Role in Parkinsons Disease
Current Protein & Peptide Science The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets
Anti-Cancer Agents in Medicinal Chemistry Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer's Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting Aβ Accumulation
CNS & Neurological Disorders - Drug Targets Antipsoriatic Drug Development: Challenges and New Emerging Therapies
Recent Patents on Inflammation & Allergy Drug Discovery Granular Non-Fibrillar Aggregates and Toxicity in Alzheimer’s Disease
Current Alzheimer Research Drug Targeting to the Brain - A Review
Current Nanoscience Hepatocyte Growth Factor (HGF): Neurotrophic Functions and Therapeutic Implications for Neuronal Injury/Diseases
Current Signal Transduction Therapy The 9p21 Locus and its Potential Role in Atherosclerosis Susceptibility; Molecular Mechanisms and Clinical Implications
Current Pharmaceutical Design Endogenous Events Modulating Myogenic Regulation of Cerebrovascular Function
Current Vascular Pharmacology Nutrient-By-Genotype Interactions and Personalized Diet: What Can We Learn From Drosophila and Evolutionary Biology?
Current Pharmacogenomics and Personalized Medicine Renin-Angiotensin System in Central Nervous System Diseases and its Interaction with COVID-19
Current Medicinal Chemistry Occupational Complexity and Leisure Activities in Cognitive Aging
Current Psychopharmacology The Small Heat Shock Protein HspB8: Role in Nervous System Physiology and Pathology
CNS & Neurological Disorders - Drug Targets Molecular Chaperones as Rational Drug Targets for Parkinsons Disease Therapeutics
CNS & Neurological Disorders - Drug Targets Pathology Associated Memory Deficits in Swedish Mutant Genome-Based Amyloid Precursor Protein Transgenic Mice
Current Aging Science Detection of Mild Cognitive Impairment Based on Virtual Reality: A Scoping Review
Current Alzheimer Research The MMP-2/TIMP-2 System in Alzheimer Disease
CNS & Neurological Disorders - Drug Targets Network Analysis of Depressive Symptomatology in Elderly Patients with Major Depressive Disorder
Current Psychiatry Research and Reviews Is Alzheimers Disease a Myth? When is Disease a Disease?
Current Alzheimer Research Targeting the NMDA Receptor for Fear-Related Disorders
Recent Patents on CNS Drug Discovery (Discontinued)